Cargando…

Delivery of seasonal malaria chemoprevention with enhanced infection prevention and control measures during the COVID-19 pandemic in Nigeria, Burkina Faso and Chad: a cross-sectional study

BACKGROUND: Seasonal malaria chemoprevention (SMC) is a WHO-recommended intervention for children aged 3–59 months living in areas of high malaria transmission to provide protection against malaria during the rainy season. Operational guidelines were developed, based on WHO guidance, to support coun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Charlotte, Phillips, Abimbola, Oresanya, Olusola, Olisenekwu, Gloria, Arogunade, Ekundayo, Moukénet, Azoukalné, Beakgoubé, Honoré, De Paul Allambademel, Vincent, Compaoré, Cheick Saïd, Traoré, Adama, Ouedraogo, Jean-Bosco, Compaoré, Yves Daniel, Zongo, Issaka, Donovan, Laura, Decola, Monica Anna, Smith, Helen, Baker, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943494/ https://www.ncbi.nlm.nih.gov/pubmed/35331248 http://dx.doi.org/10.1186/s12936-022-04091-z

Ejemplares similares

Extending Delivery of Seasonal Malaria Chemoprevention to Children Aged 5–10 Years in Chad: A Mixed-Methods Study
por: Moukénet, Azoukalné, et al.
Publicado: (2022)

Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria
por: de Cola, Monica Anna, et al.
Publicado: (2022)

Health management information system (HMIS) data quality and associated factors in Massaguet district, Chad
por: Moukénet, Azoukalné, et al.
Publicado: (2021)

Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo
por: Ibinaiye, Taiwo, et al.
Publicado: (2023)

Modeled Impact of Seasonal Malaria Chemoprevention on District-Level Suspected and Confirmed Malaria Cases in Chad Based on Routine Clinical Data (2013–2018)
por: Richardson, Sol, et al.
Publicado: (2021)

Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change
por: Zongo, Issaka, et al.
Publicado: (2020)

Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso
por: Somé, Anyirékun Fabrice, et al.
Publicado: (2016)

Knowledge and practices surrounding malaria and LLIN use among Arab, Dazagada and Fulani pastoral nomads in Chad
por: Moukénet, Azoukalné, et al.
Publicado: (2022)

Knowledge and social beliefs of malaria and prevention strategies among itinerant Nomadic Arabs, Fulanis and Dagazada groups in Chad: a mixed method study
por: Moukénet, Azoukalné, et al.
Publicado: (2022)

Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso
por: Tiba, Fabrice, et al.
Publicado: (2012)

Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso
por: Compaoré, Rachidatou, et al.
Publicado: (2017)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
por: Chotsiri, Palang, et al.
Publicado: (2019)

Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso
por: Compaoré, Yves Daniel, et al.
Publicado: (2021)

Social perceptions of malaria and diagnostic-driven malaria treatment in Burkina Faso
por: Traore, Orokia, et al.
Publicado: (2021)

Enhanced effect of seasonal malaria chemoprevention when coupled with nutrients supplementation for preventing malaria in children under 5 years old in Burkina Faso: a randomized open label trial
por: Sondo, Paul, et al.
Publicado: (2023)

Serotype Profile of Nasopharyngeal Isolates of Streptococcus pneumoniae Obtained from Children in Burkina Faso before and after Mass Administration of Azithromycin
por: Hema-Ouangraoua, Soumeya, et al.
Publicado: (2020)

Molecular Characterization and the Antimicrobial Resistance Profile of Salmonella spp. Isolated from Ready-to-Eat Foods in Ouagadougou, Burkina Faso
por: Soubeiga, Adama Patrice, et al.
Publicado: (2022)

Amendment with Burkina Faso phosphate rock-enriched composts alters soil chemical properties and microbial structure, and enhances sorghum agronomic performance
por: Sagnon, Adama, et al.
Publicado: (2022)

Availability and Utilization of Postabortion Care Services in Burkina Faso, Côte d’Ivoire, and Guinea: A Secondary Analysis of Emergency Obstetric and Neonatal Care Needs Assessments (EmONC)
por: Compaore, Rachidatou, et al.
Publicado: (2022)

Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger
por: Somé, Anyirékun Fabrice, et al.
Publicado: (2022)

Countrywide Survey of Plants Used for Liver Disease Management by Traditional Healers in Burkina Faso
por: Tibiri, André, et al.
Publicado: (2020)

Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness
por: Yaméogo, Koudraogo Bienvenue, et al.
Publicado: (2021)

Breast cancer in West Africa: molecular analysis of BRCA genes in early-onset breast cancer patients in Burkina Faso
por: Biancolella, Michela, et al.
Publicado: (2021)

Predictors of contraceptive method discontinuation among adolescent and young women in three West African countries (Burkina Faso, Mali, and Niger)
por: Ouédraogo, Adja Mariam, et al.
Publicado: (2021)

Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
por: Sondo, Paul, et al.
Publicado: (2021)

Impact of seasonal RTS,S/AS01(E) vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali
por: Grant, Jane, et al.
Publicado: (2022)

Assessing the Quality of Burkina Faso Soybeans Based on Fatty Acid Composition and Pesticide Residue Contamination
por: Ouédraogo, Elisabeth Rakiswendé, et al.
Publicado: (2022)

APOBEC3G expression and HIV-1 infection in Burkina Faso
por: Compaore, Tegwinde Rebeca, et al.
Publicado: (2018)

Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria
por: de Wit, Mariken, et al.
Publicado: (2021)

Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention
por: Yaro, Jean Baptiste, et al.
Publicado: (2022)

La cardiothyréose au centre hospitalier universitaire de Bobo-Dioulasso, Burkina Faso
por: Yaméogo, Aimé Arsène, et al.
Publicado: (2012)

APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso
por: Compaore, Tegwinde Rebeca, et al.
Publicado: (2016)

How to Estimate Optimal Malaria Readiness Indicators at Health-District Level: Findings from the Burkina Faso Service Availability and Readiness Assessment (SARA) Data
por: Rouamba, Toussaint, et al.
Publicado: (2020)

Hepatitis B, C, and D virus and human T-cell leukemia virus types 1 and 2 infections and correlates among men who have sex with men in Ouagadougou, Burkina Faso
por: Ouedraogo, Henri Gautier, et al.
Publicado: (2018)

Skin oncoplasties: O-to-Z technique a technique of choice in situation of limited resources? Case of Burkina Faso
por: Zongo, Nayi, et al.
Publicado: (2022)

Performance-based financing to increase utilization of maternal health services: Evidence from Burkina Faso()
por: Steenland, Maria, et al.
Publicado: (2017)

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
por: Gansané, Adama, et al.
Publicado: (2021)

Cancer of the vulva in Burkina Faso: a hospital-based case series
por: Zongo, Nayi, et al.
Publicado: (2016)

Lipome cervical géant : À propos d'un cas à Ouagadougou, Burkina Faso
por: KADYOGO, Moussa, et al.
Publicado: (2022)

HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso
por: Compaore, Tegwinde Rebeca, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f0hvfkia1m3smt0gcc68h6mr1i